Could the iPhone 17 Pro be set to revolutionize mobile photography? A recent leak hints at exciting new camera features, including a second Camera Control. Is this the future of iPhone photography?
A groundbreaking study reveals that spiders might have ancient marine origins, based on a 500-million-year-old fossil that challenges our understanding of arachnid evolution. This discovery reshapes the narrative around how these creatures adapted from sea to land!
A coalition of 21 states has filed a lawsuit against the USDA's demand for personal SNAP applicant data, claiming it violates privacy laws and threatens food assistance programs.
German scientists have made a groundbreaking leap by creating solar cells from lunar dust, paving the way for sustainable energy production on the Moon and advancing plans for lunar colonies.
A groundbreaking study reveals that groundwater pumping has shifted Earth's rotational axis by 31.5 inches, raising concerns about climate change and sea-level rise. Discover the surprising implications of this human activity!
A horrific shooting at the Grand Sierra Resort in Reno has left three dead and multiple others injured. The suspect is in critical condition after a violent series of events unfolded in the valet area. Police are investigating the motive behind this tragic incident.
A groundbreaking study reveals that the long-dormant Tintina fault in Canada's Yukon Territory shows signs of seismic activity, suggesting a potential future earthquake threat. Researchers have identified evidence of past earthquakes that could mean the fault is still active.
Procter & Gamble announces Shailesh Jejurikar will take over as CEO in 2026, succeeding Jon Moeller, who transitions to executive chairman. Discover Jejurikar's inspiring journey from India to the top of P&G!
As the Fed prepares for a crucial meeting, President Trump faces disappointment as interest rates are likely to remain unchanged. With rising tariffs and inflation concerns, a debate brews among Fed governors about the need for a rate cut.
In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
